SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-24-012375
Filing Date
2024-09-27
Accepted
2024-09-27 08:14:24
Documents
5
Period of Report
2024-10-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A tenx_def14a.htm DEF 14A 450146
2 tenx_def14aimg3.jpg GRAPHIC 7596
3 tenx_def14aimg4.jpg GRAPHIC 24283
4 tenx_def14aimg5.jpg GRAPHIC 117956
5 tenx_def14aimg6.jpg GRAPHIC 123678
  Complete submission text file 0001654954-24-012375.txt   828654
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-34600 | Film No.: 241330616
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)